Digiandomenico Anthony
SEC-identified person · CIK 1083544 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Clearsign Technologies Corp CLIR | Director | filed 2025 - 2026 |
| Illumination Acquisition Corp. I ILLU | Director | filed 2026 - 2026 |
| Endra Life Sciences Inc. NDRA | Director | filed 2017 - 2026 |
| MDB Capital Holdings, LLC MDBH? | Director · Co-Founder | filed 2023 - 2025 |
| Invizyne Technologies Inc IZTC | Director | filed 2024 - 2024 |
| Provention Bio, Inc. PRVB] | Director | filed 2018 - 2020 |
| Cue Biopharma, Inc. CUE | Director | filed 2017 - 2019 |
| Xelr8 Holdings, INC. XELR.OB | Director | filed 2006 - 2012 |
| Pier Acquisition I, Inc. | Director | filed 2009 - 2009 |
| Pier Acquisition II, Inc. | Director | filed 2009 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.